Gemvax
2001
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Developer and manufacturer of pharmaceutical products. The company is focused on the development of peptide vaccines, which are innovative immunotherapeutic anti-cancer drugs.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Teknologisenteret
- Kjølnes Ring
- 3918 Porsgrunn
- Norway
Gemvax Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Gemvax‘s full profile, request access.
Request full access to PitchBookGemvax Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Gemvax‘s full profile, request access.
Request full access to PitchBook